ArticlePloS one2026
Optimization, characterization and biological activity of siderophore produced by marine Streptomyces coelicolor.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two Streptomyces spp. were isolated from open ocean waters of the Gulf of Mannar. Of the two isolates, one was identified as Streptomyces coelicolor through conventional and molecular approaches, and it was found to produce a siderophore. Characterization revealed the siderophore to be of trihydroxamate type with hexadentate iron-binding capacity. FTIR analysis indicated the presence of aromatic rings with C-O and C = C stretching, while 1H and 13C NMR together with mass spectrometry confirmed the hydroxamate nature and identified the siderophore as ferrioxamine. A narrow shift in λ max indicate the photoreactive nature of the siderophore on exposure to sunlight. The cell-free supernatant of S. coelicolor and the purified siderophore dose-dependently inhibited the growth of microbial pathogens. Quorum quenching activity was confirmed using the indicator strain Chromobacterium violaceum. Both the cell-free supernatant and siderophore were found to inhibit biofilm formation and induce reactive oxygen species (ROS) generation in pathogens. The siderophore also suppressed the proliferation of the breast cancer cell line (MCF-7) by disturbing iron homeostasis. Optimization of International Streptomyces Project (ISP2) medium constituents using two-level factorial design and response surface methodology (RSM) enabled cost-effective siderophore production. In addition to iron, the siderophore exhibited binding affinity for other heavy metals including zinc, cobalt, cadmium, lead, and magnesium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.